Evidence reviewed: 8 November 2026. A ketogenic diet is a very-low-carbohydrate, relatively high-fat eating pattern designed to increase the body’s production of ketone bodies. Carefully supervised ketogenic dietary therapy is an established treatment for selected drug-resistant epilepsies. For weight loss and type 2 diabetes, some individuals experience short-term improvements in weight and glucose control, but long-term benefits are less certain, adherence can be difficult and the diet is not suitable for everyone. Importantly, the American Diabetes Association (ADA) 2026 Standards of Care warn that ketogenic diets should be avoided in people using SGLT2 inhibitors because of the risk of ketoacidosis [1,2].
What is a ketogenic diet?
Ketogenic eating sharply restricts carbohydrate intake, often to approximately 20–50 g per day in weight-management versions, while increasing the proportion of energy from fats and maintaining adequate protein. Exact carbohydrate limits vary according to the person, energy needs and whether the plan is a medically prescribed epilepsy therapy. Traditional therapeutic ketogenic diets for epilepsy may use specified fat-to-combined-protein-and-carbohydrate ratios such as 3:1 or 4:1, while modified Atkins and low-glycemic-index therapies are less restrictive alternatives under specialist supervision [2].
There is no single standard ketogenic menu for all patients. Strict diet prescriptions are inappropriate for some medical conditions and can compromise fiber, vitamin and mineral intake if poorly designed.
Nutritional ketosis versus diabetic ketoacidosis
When carbohydrate intake is very low, insulin signals and liver glycogen availability change, and the liver increases production of beta-hydroxybutyrate, acetoacetate and acetone from fatty acids. These ketone bodies can provide fuel to several tissues, including the brain after adaptation. Nutritional ketosis is a regulated metabolic state that may occur during carbohydrate restriction or fasting.
Diabetic ketoacidosis (DKA) is different: it is a dangerous condition involving insufficient effective insulin action, excessive ketone production, blood acidification and often dehydration. It can be life-threatening. SGLT2 inhibitor-associated DKA can occur with only moderately elevated or even relatively normal glucose levels (euglycemic DKA); a normal home glucose reading cannot exclude it [1].
Seek emergency medical care for nausea, vomiting, abdominal pain, unusual rapid or deep breathing, severe weakness, confusion or dehydration in someone with diabetes who may have ketoacidosis. Do not assume these are ordinary ‘keto adaptation’ symptoms.
Established medical use: ketogenic dietary therapy for epilepsy
Ketogenic dietary therapies (KDTs) have decades of clinical use in selected children and adults with drug-resistant epilepsy. They are ordinarily managed by a specialist team including a neurologist and dietitian. For some individuals, the therapy meaningfully reduces seizure frequency; for a subset it can provide substantial control. Other patients do not respond, and improvement cannot be predicted from a simplistic ketone-level formula [2].
Prior to treatment, clinicians assess seizure type, growth or nutrition, relevant metabolic disorders, kidney stones, constipation, lipid profile, medications and family capacity to implement the plan. Inborn errors of fatty-acid oxidation, primary carnitine deficiency and certain other metabolic diseases are contraindications because the patient may be unable to safely use fat as the main fuel. Follow-up can include blood chemistry, kidney and liver function, lipid levels, growth, bone health and micronutrient adequacy [2].
Never stop antiseizure medicines because dietary ketosis begins. Medication changes require specialist decisions based on clinical response and safety. A high-fat diet started independently at home is not equivalent to a prescribed epilepsy treatment protocol.
Can keto help with weight management?
Some adults find very-low-carbohydrate diets reduce appetite and simplify food choices, leading to a calorie deficit and weight loss. Early weight changes often include water loss as glycogen and associated water decline. Randomized trials comparing diet patterns have found that long-term weight outcomes depend heavily on adherence and energy intake, with no consistent evidence that everyone achieves superior durable weight loss through ketosis alone.
The ADA recognizes that lower-carbohydrate eating can be one option for selected adults with diabetes, but it emphasizes an individualized, nutrient-dense eating pattern and appropriate medical oversight [1]. There is no reason to assume that a strict ketogenic diet is more suitable than Mediterranean-style eating, calorie reduction with adequate protein, or another sustainable approach for every person.
Type 2 diabetes: potential benefits and important hazards
Restricting carbohydrate can reduce post-meal glucose excursions and may improve average glucose measures in some people, especially when weight decreases. However, medication requirements can change quickly. People taking insulin or sulfonylureas may experience hypoglycemia if they suddenly reduce carbohydrate without a supervised medication review. People taking blood-pressure medicines or diuretics may experience dizziness or changes in fluid balance.
The 2026 ADA Standards of Care state that very-low-carbohydrate diets should be avoided while taking SGLT2 inhibitors—for example, empagliflozin, dapagliflozin or canagliflozin—because DKA, including euglycemic DKA, has occurred with this combination. Diabetes patients must not stop or adjust their own medications to attempt ketogenic eating. A clinician should weigh any dietary change against glucose control, ketoacidosis risk, cardiovascular health and other individual factors [1].
Type 1 diabetes is especially high risk without careful specialist management: insulin deficiency can rapidly cause DKA. A self-directed ketogenic diet is not a substitute for insulin, continuous glucose monitoring or prescribed diabetes care.
What about LDL cholesterol and cardiovascular health?
Ketogenic diets are not uniformly cardioprotective. Some people experience reductions in triglycerides and increases in HDL cholesterol, but LDL cholesterol and apolipoprotein B (apoB) can rise substantially, especially when carbohydrate is replaced with large amounts of butter, fatty processed meats, coconut oil or other saturated-fat sources. This is important because elevated LDL/apoB is causally associated with atherosclerotic cardiovascular disease.
The AHA’s 2026 dietary statement favors replacing saturated fats with unsaturated fats and prioritizing vegetables, whole grains, legumes and high-quality proteins [3]. A ketogenic diet based mainly on processed meat, cheese and saturated fat may conflict with those goals. If a clinician considers a carbohydrate-restricted plan appropriate, choose more unsaturated fats and plant foods where compatible, and monitor lipid levels. Do not assume weight loss neutralizes an important rise in LDL cholesterol.
Potential adverse effects and nutritional gaps
- Constipation and inadequate fiber when whole grains, fruit and legumes are greatly restricted.
- Headache, fatigue, dizziness or cramps during early dietary changes, sometimes worsened by fluid or electrolyte shifts.
- Low intake of certain vitamins and minerals if food choices are narrow or supplements are poorly planned.
- Elevated LDL cholesterol in some individuals.
- Kidney stones, especially with medically prescribed long-term ketogenic therapy in susceptible patients.
- Bone or growth concerns in children undergoing long-term restrictive epilepsy therapy without appropriate monitoring.
- Medication-related hypoglycemia or ketoacidosis in people with diabetes, depending on treatment.
The International Ketogenic Diet Study Group recommends active assessment and monitoring for side effects in children receiving therapeutic KDT, not assuming that any state of ketosis is harmless [2].
Who should avoid a self-directed ketogenic diet?
The ADA advises that very-low-carbohydrate plans are not currently recommended during pregnancy or lactation, in children, in people with kidney disease, or in those with or at risk for disordered eating [1]. This refers to routine lifestyle diets; specialist-prescribed ketogenic therapy for particular pediatric epilepsies is a distinct supervised medical intervention.
Additional reasons for specialist review include type 1 diabetes, use of SGLT2 inhibitors, major liver or pancreatic disease, conditions requiring specific carbohydrate or electrolyte management, and known metabolic disorders. Individuals with existing kidney stones, severe dyslipidemia or nutritional deficiencies need personalized risk-benefit evaluation rather than a generic internet meal plan.
Planning a safer low-carbohydrate approach when clinically appropriate
For adults approved by a clinician to use carbohydrate restriction, nutritional quality and follow-up still matter. A more thoughtful approach includes:
- Clarify the medical goal. Epilepsy treatment, weight management and glucose control have different risks and evidence.
- Review medications first. Especially insulin, sulfonylureas, SGLT2 inhibitors, diuretics and blood-pressure medicines.
- Choose higher-quality fats. Olive oil, avocado, nuts, seeds and appropriate fish in place of relying heavily on butter and processed meats.
- Include nonstarchy vegetables. Leafy greens, broccoli, peppers, cucumber and other suitable plants provide fiber and micronutrients.
- Keep protein appropriate. Eggs, fish, tofu, poultry and other sources may be suitable, with adjustments for kidney or other conditions.
- Monitor clinical measures. Relevant parameters may include blood pressure, symptoms, weight trends, glucose and medication needs, lipid profile and renal function.
- Reassess sustainability. If the pattern compromises nutrition, worsens LDL or causes distress, consider another evidence-supported approach.
Strict ketosis is not required to improve many cardiovascular or metabolic risk factors. See our Mediterranean diet for heart health article for a less restrictive dietary pattern with established cardiovascular evidence.
Are ketone meters necessary?
Specialist ketogenic therapy for epilepsy may use blood beta-hydroxybutyrate or urine ketone monitoring according to its protocol. However, there is no validated ketone target that guarantees greater weight loss or cardiovascular benefit for healthy adults. In diabetes, ketone measurement may be medically necessary to evaluate suspected ketoacidosis, but ketone readings must not be interpreted without clinical context. Severe symptoms require urgent care even if a home meter is unavailable.
Keto, cancer and neurological diseases: what is established?
Outside selected epilepsies, evidence for ketogenic diets as a treatment for cancer, Alzheimer’s disease or Parkinson’s disease remains insufficient for routine clinical recommendation. Small studies and experimental mechanisms may be interesting but do not establish that ketosis can replace chemotherapy, immunotherapy or neurologic medications. Claims that a ketogenic diet ‘starves cancer’ are an oversimplification of complex tumor metabolism.
Frequently asked questions
Is nutritional ketosis the same as DKA?
No. Nutritional ketosis is a regulated response to carbohydrate restriction; DKA involves dangerous metabolic acidosis and is a medical emergency [1].
Does a ketogenic diet cure type 2 diabetes?
No. Some patients improve glucose or weight, but there is no universal cure. Ongoing assessment and medication safety remain essential.
Can I use keto while taking empagliflozin or dapagliflozin?
Avoid combining very-low-carbohydrate or ketogenic eating with SGLT2 inhibitors. The 2026 ADA Standards warn of DKA risk [1].
Is keto better than a Mediterranean diet for heart health?
Not as a universal claim. Some keto approaches raise LDL cholesterol, while Mediterranean-style eating aligns closely with AHA heart-health guidance [3].
Can a child with epilepsy start a ketogenic diet at home?
No. Epilepsy ketogenic therapy should be prescribed and monitored by a specialist team because metabolic contraindications and nutritional complications must be assessed [2].
Does high urine ketone concentration mean better weight loss?
No. Urine ketone levels vary and do not reliably measure whether a diet is producing healthy long-term outcomes.
Key takeaways
Ketogenic dietary therapy is established for selected epilepsies, but lifestyle keto requires individualized assessment. Potential weight and glucose benefits should be balanced against nutrient gaps, elevated LDL in some people and serious diabetes medication risks. A person taking an SGLT2 inhibitor should avoid a very-low-carbohydrate ketogenic plan under current ADA recommendations.
References
- American Diabetes Association Professional Practice Committee. Facilitating positive health behaviors and well-being to improve health outcomes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1). Full text.
- Kossoff EH, Zupec-Kania BA, Auvin S, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;3(2):175–192. doi:10.1002/epi4.12225. PubMed.
- Lichtenstein AH, et al. 2026 dietary guidance to improve cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2026. AHA summary.
Medical disclaimer: General education only. Ketogenic eating may cause serious harm in some conditions and can interact with medications. Do not make major carbohydrate reductions or adjust diabetes/epilepsy medications without professional advice. Seek emergency care for suspected ketoacidosis.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.